Case number 1:22-cv-01209
AstraZeneca AB et al v. Annora Pharma Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 23, 2022 | 10 | PROPOSED Consent Judgment, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) Modified on 11/23/2022 (nms). (Entered: 11/23/2022) (3) |
| Nov 23, 2022 | 11 | CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 11/23/2022. (nms) (Entered: 11/23/2022) (3) |
| Nov 23, 2022 | 12 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1 Consent Judgment)(nms) (Entered: 11/23/2022) (Main Document) (1) |
| Nov 23, 2022 | 12 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1 Consent Judgment)(nms) (Entered: 11/23/2022) (Consent Judgment) (3) |
| Sep 19, 2022 | 7 | WAIVER OF SERVICE returned executed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For Annora Pharma Private Limited waiver sent on 9/19/2022, answer due 11/18/2022. (Joyce, Alexandra) (Entered: 09/19/2022) (1) |
| Sep 19, 2022 | 8 | WAIVER OF SERVICE returned executed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For Hetero Labs Limited waiver sent on 9/19/2022, answer due 11/18/2022. (Joyce, Alexandra) (Entered: 09/19/2022) (1) |
| Sep 19, 2022 | 9 | WAIVER OF SERVICE returned executed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For Hetero USA, Inc. waiver sent on 9/19/2022, answer due 11/18/2022. (Joyce, Alexandra) (Entered: 09/19/2022) (1) |
| Sep 15, 2022 | 1 | Complaint* (1) |
| Sep 15, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 09/15/2022) (3) |
| Sep 15, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/01/2022. Date of Expiration of Patent: 01/27/2036.Thirty Month Stay Deadline: 2/1/2025. (vfm) (Entered: 09/19/2022) (2) |
| Sep 15, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (vfm) (Entered: 09/19/2022) (1) |
| Sep 15, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (vfm) (Entered: 09/19/2022) (2) |
| Sep 15, 2022 | 6 | Summons Issued as to Hetero USA, Inc.. (vfm) (Entered: 09/19/2022) (2) |
